To Our Esteemed NOMA Family and Friends,

I am honored to be able to thank all of you who attended our recent Winter Symposium in Lake Tahoe. Your continued support has resulted in one of the best-attended conferences in our recent history, despite the lack of snow for a ski conference! The feedback we received regarding our speakers was also unprecedented in the level of approval and satisfaction. This is extremely gratifying as we continue to strive to bring you the best speakers and the latest pertinent topics that we can provide. Presentation slides will be up on our website soon at www.nevadaosteopathic.org and CME certificates will be in the mail shortly!

As NOMA continues to strive to bring you the best in quality continuing medical education, I am excited to announce that we also will be evolving our multi-day conferences to include breakout sessions beyond ACLS. We hope to develop programs such as In Depth Osteopathic Skills Review, Therapeutic Injections Workshop, and possibly parallel tracks offering specialty credits.

Again from all of us to all of you, thank you for being part of this exciting chapter in NOMA's ascendancy.

Hope to see all of you at our Annual Meeting in Las Vegas!

God Bless and Have a Great Day;

Bruce Fong, DO
President
Nevada Osteopathic Medical Association

Governor Sandoval's Controlled Substance Abuse Prevention Act ("AB 474"), a bill that regulates how physicians prescribe controlled substances, goes into effect on January 1, 2018 

The Department of Health and Human Services (DHHS) has recently launched its Prescribe365.NV.GOV page. This page contains a number of resources for prescribers specific to the implementation of AB474 and are intended to support providers in their compliance with the bill. 

On this page you will find the following,

AB474 FAQs

Resources for Prescribers, including

  • The White Paper created by the Boards
  • Compliance check lists
  • Sample Informed Consent
  • Sample Medication Agreement
  • Sample Hospice Informed Consent

Public Service Announcements

NOMA is continuing its efforts to develop our own unique set of tools to make prescribing under the new laws easier.  These resources should be available soon, so check back frequently for updated information.

As part of NOMA's continued commitment to you, I would like to report on recent meetings that I have had with the Governor's Staff regarding the implementation of AB474 or "the controlled substances bill." I attended a meeting on November 30th along with many other professional societies and practice groups to review samples of documentation forms that will be required after January 1, 2018 to prescribe controlled substances for pain. Specifically, we have repeatedly asked for clarification from the Pharmacy Board and have received a verbal answer at these meetings that INFORMED CONSENT, the CONTROLLED SUBSTANCE MEDICATION AGREEMENT and the RISK FOR ADDICTION ASSESSMENTS are STRICTLY FOR CONTROLLED SUBSTANCES FOR PAIN (i.e.: opiates). This is despite the law in its final form being somewhat unclear on this.

Currently no one (i.e.: licensing boards or State) will put out a written clarification on this matter. I intend to push harder for this, and I will keep you informed.

Otherwise we were able to agree on format and language on the prescriptions but still have issues to iron out on sample forms for the other documentation. especially the informed consent. Again I will keep you posted.

Below, you will find links to the Pharmacy Board's One Page "Cheat Sheet," the Nursing Board's extensive flow sheet to approaching these patients, and the sample prescription. We are also working on our own concise and easy to understand flow sheets.

Again NOMA will be monitoring and trying to help alleviate fears regarding the new law's impending implementation.

God Bless,

Bruce Fong, DO
President

Attachments:
Download this file (2017 09 01 AB 474 Chart (FINAL).pdf)AB 474 Chart[ ]635 kB
Download this file (NSBN AB474 checklist.doc)NSBN AB474 checklist[ ]49 kB
Download this file (Sample Prescription.doc)Sample Prescription[ ]27 kB